Literature DB >> 26239008

The Relationship Between Trimethylamine-N-Oxide and Prevalent Cardiovascular Disease in a Multiethnic Population Living in Canada.

Andrew Mente1, Kenneth Chalcraft2, Handan Ak2, A Darlene Davis3, Eva Lonn4, Ruby Miller3, Murray A Potter2, Salim Yusuf5, Sonia S Anand5, Matthew J McQueen6.   

Abstract

BACKGROUND: Microflora-dependent trimethylamine-N-oxide (TMAO) formation, which results from intake of choline and L-carnitine-rich food, shows promise as a predictor of cardiovascular disease (CVD) risk, but these associations have not been examined in ethnically diverse populations. In a multiethnic population-based study of adults in Canada, we assessed the stability of TMAO and L-carnitine in stored serum samples and their association with intimal medial thickness, prevalent risk factors, and clinical events.
METHODS: In a randomly sampled cross-sectional study of 1286 Canadians, fasting serum samples were collected and stored. In 292 consecutive individuals (99 CVD cases and 193 unmatched control subjects), L-carnitine and TMAO concentrations were assessed using validated analytical approaches.
RESULTS: The mean (± SD) TMAO level was 1.998 ± 3.13 μM and L-carnitine was 42.29 ± 11.35 μM. The relative levels of the samples did not appreciably change after 3 freeze-thaw cycles (coefficient of variation, 5.6% and 4.7%, respectively). No significant association between L-carnitine levels and prevalent CVD was found, with adjustment for covariates (odds ratio, 1.57; 95% confidence interval, 0.58-4.26; P trend = 0.65), for highest vs lowest quintile group. TMAO levels showed a significant, graded association with prevalent CVD (odds ratio, 3.17; 95% confidence interval, 1.05-9.51; P trend = 0.02). After further adjustment for diabetes status, meat, fish, and cholesterol intake, the association remained significant. No significant association between carotid intimal medial thickness and L-carnitine (P = 0.64) or TMAO (P = 0.18) was found.
CONCLUSIONS: Serum TMAO and L-carnitine analysis on stored samples is reliable. Our findings support an association between TMAO with prevalent CVD in a multiethnic population. This finding requires replication in larger studies in which dietary intake and stored serum samples exist.
Copyright © 2015 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26239008     DOI: 10.1016/j.cjca.2015.06.016

Source DB:  PubMed          Journal:  Can J Cardiol        ISSN: 0828-282X            Impact factor:   5.223


  54 in total

1.  Trimethylamine N-Oxide and Cardiovascular Events in Hemodialysis Patients.

Authors:  Tariq Shafi; Neil R Powe; Timothy W Meyer; Seungyoung Hwang; Xin Hai; Michal L Melamed; Tanushree Banerjee; Josef Coresh; Thomas H Hostetter
Journal:  J Am Soc Nephrol       Date:  2016-07-19       Impact factor: 10.121

2.  Non-lethal Inhibition of Gut Microbial Trimethylamine Production for the Treatment of Atherosclerosis.

Authors:  Zeneng Wang; Adam B Roberts; Jennifer A Buffa; Bruce S Levison; Weifei Zhu; Elin Org; Xiaodong Gu; Ying Huang; Maryam Zamanian-Daryoush; Miranda K Culley; Anthony J DiDonato; Xiaoming Fu; Jennie E Hazen; Daniel Krajcik; Joseph A DiDonato; Aldons J Lusis; Stanley L Hazen
Journal:  Cell       Date:  2015-12-17       Impact factor: 41.582

Review 3.  [Gut-heart axis : How gut bacteria influence cardiovascular diseases].

Authors:  Hendrik Bartolomaeus; Victoria McParland; Nicola Wilck
Journal:  Herz       Date:  2020-04       Impact factor: 1.443

Review 4.  Targeting of microbe-derived metabolites to improve human health: The next frontier for drug discovery.

Authors:  J Mark Brown; Stanley L Hazen
Journal:  J Biol Chem       Date:  2017-04-07       Impact factor: 5.157

Review 5.  Understanding the Holobiont: How Microbial Metabolites Affect Human Health and Shape the Immune System.

Authors:  Thomas Siegmund Postler; Sankar Ghosh
Journal:  Cell Metab       Date:  2017-06-15       Impact factor: 27.287

6.  Intake of up to 3 Eggs/Day Increases HDL Cholesterol and Plasma Choline While Plasma Trimethylamine-N-oxide is Unchanged in a Healthy Population.

Authors:  Diana M DiMarco; Amanda Missimer; Ana Gabriela Murillo; Bruno S Lemos; Olga V Malysheva; Marie A Caudill; Christopher N Blesso; Maria Luz Fernandez
Journal:  Lipids       Date:  2017-01-13       Impact factor: 1.880

Review 7.  Role of gut microbiota in atherosclerosis.

Authors:  Annika Lindskog Jonsson; Fredrik Bäckhed
Journal:  Nat Rev Cardiol       Date:  2016-12-01       Impact factor: 32.419

8.  Trimethylamine-N-oxide and its biological variations in vegetarians.

Authors:  Rima Obeid; Hussain M Awwad; Markus Keller; Juergen Geisel
Journal:  Eur J Nutr       Date:  2016-08-25       Impact factor: 5.614

9.  Editor's Highlight: PCB126 Exposure Increases Risk for Peripheral Vascular Diseases in a Liver Injury Mouse Model.

Authors:  Banrida Wahlang; Jazmyne Barney; Brendan Thompson; Chunyan Wang; Omer M Hamad; Jessie B Hoffman; Michael C Petriello; Andrew J Morris; Bernhard Hennig
Journal:  Toxicol Sci       Date:  2017-12-01       Impact factor: 4.849

10.  Intermittent Hypoxia and Hypercapnia Accelerate Atherosclerosis, Partially via Trimethylamine-Oxide.

Authors:  Jin Xue; Dan Zhou; Orit Poulsen; Toshihiro Imamura; Yu-Hsin Hsiao; Travis H Smith; Atul Malhotra; Pieter Dorrestein; Rob Knight; Gabriel G Haddad
Journal:  Am J Respir Cell Mol Biol       Date:  2017-11       Impact factor: 6.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.